Portside Wealth Group
VRTX icon

Portside Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Portside Wealth Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.55M Sell
4,874
-384
-7% -$197K 0.28% 78
2026
Q2 		$2.61M Buy
5,258
+434
+9% +$192K 0.3% 74
2026
Q1 		$2.15M Buy
4,824
+510
+12% +$238K 0.29% 82
2025
Q4 		$1.96M Buy
4,314
+571
+15% +$246K 0.26% 82
2025
Q3 		$1.47M Buy
3,743
+545
+17% +$228K 0.2% 114
2025
Q2 		$1.42M Buy
3,198
+253
+9% +$117K 0.21% 107
2025
Q1 		$1.43M Buy
2,945
+679
+30% +$316K 0.23% 102
2024
Q4 		$913K Buy
2,266
+261
+13% +$121K 0.15% 148
2024
Q3 		$932K Buy
2,005
+193
+11% +$92.7K 0.16% 146
2024
Q2 		$849K Buy
1,812
+30
+2% +$13K 0.16% 142
2024
Q1 		$745K Buy
1,782
+126
+8% +$53.3K 0.14% 161
2023
Q4 		$674K Buy
1,656
+144
+10% +$53.2K 0.13% 176
2023
Q3 		$522K Buy
1,512
+226
+18% +$79K 0.1% 189
2023
Q2 		$453K Buy
+1,286
New +$433K 0.08% 208

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Portside Wealth Group's VRTX Position: Q3 2026 in Review

Portside Wealth Group reduced its Vertex Pharmaceuticals (VRTX) stake by 7.3% in Q3 2026, selling an estimated $197K and leaving 4,874 shares worth $2.55M. The position accounts for 0.28% of the portfolio, ranked #78.

Portside Wealth Group first reported a position in VRTX in Q2 2023 and has held it in 14 quarters since. The position peaked at $2.61M in Q2 2026. 386 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Portside Wealth Group held 4,874 shares of Vertex Pharmaceuticals worth $2.55M as of Q3 2026.
  • Portside Wealth Group sold 384 Vertex Pharmaceuticals shares in Q3 2026, an estimated $197K.
  • Vertex Pharmaceuticals made up 0.28% of Portside Wealth Group's portfolio in Q3 2026, its #78 holding.
  • Portside Wealth Group first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
  • Portside Wealth Group's Vertex Pharmaceuticals position peaked at $2.61M in Q2 2026.
  • 386 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.